Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China
· Delayed Price · Currency is CNY 25.95
+0.20 (0.78%)
Mar 10, 2026, 11:30 AM CST
Aurisco Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 10,459 | 8,579 | 10,488 | 10,029 | 8,830 | 6,364 | Upgrade
|
| Market Cap Growth | 27.09% | -18.20% | 4.58% | 13.58% | 38.75% | - | Upgrade
|
| Enterprise Value | 10,410 | 8,317 | 10,056 | 9,726 | 8,296 | 5,718 | Upgrade
|
| Last Close Price | 25.75 | 20.82 | 25.21 | 23.96 | 21.25 | 15.19 | Upgrade
|
| PE Ratio | 24.22 | 24.18 | 36.24 | 47.54 | 52.34 | 40.48 | Upgrade
|
| Forward PE | 22.99 | 18.69 | 30.47 | 39.82 | - | - | Upgrade
|
| PS Ratio | 6.44 | 5.81 | 8.31 | 9.95 | 10.99 | 8.82 | Upgrade
|
| PB Ratio | 4.12 | 3.68 | 5.33 | 5.96 | 5.86 | 4.59 | Upgrade
|
| P/TBV Ratio | 4.39 | 3.95 | 5.68 | 6.46 | 6.02 | 4.74 | Upgrade
|
| P/FCF Ratio | 269.24 | - | 130.89 | - | - | 114.29 | Upgrade
|
| P/OCF Ratio | 27.35 | 25.81 | 27.20 | 60.27 | 43.81 | 29.67 | Upgrade
|
| EV/Sales Ratio | 6.41 | 5.64 | 7.97 | 9.65 | 10.33 | 7.93 | Upgrade
|
| EV/EBITDA Ratio | 17.95 | 17.78 | 28.49 | 35.61 | 35.42 | 25.54 | Upgrade
|
| EV/EBIT Ratio | 21.36 | 21.53 | 36.07 | 46.71 | 45.40 | 29.80 | Upgrade
|
| EV/FCF Ratio | 267.97 | - | 125.50 | - | - | 102.69 | Upgrade
|
| Debt / Equity Ratio | 0.39 | 0.41 | 0.06 | 0.03 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 1.71 | 2.00 | 0.33 | 0.19 | 0.08 | - | Upgrade
|
| Debt / FCF Ratio | 25.52 | - | 1.46 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.02 | -0.05 | -0.22 | -0.20 | -0.28 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.09 | -0.26 | -1.22 | -1.24 | -1.82 | -2.52 | Upgrade
|
| Net Debt / FCF Ratio | -1.28 | 0.58 | -5.35 | 6.81 | 8.70 | -10.13 | Upgrade
|
| Asset Turnover | 0.42 | 0.46 | 0.55 | 0.54 | 0.49 | 0.55 | Upgrade
|
| Inventory Turnover | 1.10 | 1.15 | 1.18 | 1.28 | 1.45 | 1.60 | Upgrade
|
| Quick Ratio | 2.98 | 2.68 | 1.69 | 1.92 | 3.06 | 5.02 | Upgrade
|
| Current Ratio | 4.30 | 3.85 | 2.73 | 3.38 | 4.87 | 6.91 | Upgrade
|
| Return on Equity (ROE) | 17.65% | 16.50% | 15.83% | 13.05% | 11.63% | 13.31% | Upgrade
|
| Return on Assets (ROA) | 7.85% | 7.49% | 7.56% | 6.93% | 7.02% | 9.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.41% | 17.95% | 16.99% | 14.85% | 16.68% | 21.19% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.60% | 11.60% | 13.40% | 12.20% | 12.00% | 13.80% | Upgrade
|
| Earnings Yield | 4.06% | 4.14% | 2.76% | 2.10% | 1.91% | 2.47% | Upgrade
|
| FCF Yield | 0.37% | -2.42% | 0.76% | -0.50% | -0.56% | 0.88% | Upgrade
|
| Dividend Yield | 1.14% | 1.39% | 0.87% | 0.67% | 0.61% | 0.79% | Upgrade
|
| Payout Ratio | 29.85% | 26.72% | 23.15% | 24.81% | 28.52% | 22.90% | Upgrade
|
| Buyback Yield / Dilution | 3.69% | 2.21% | -0.48% | -1.00% | -7.31% | -4.58% | Upgrade
|
| Total Shareholder Return | 4.83% | 3.60% | 0.40% | -0.33% | -6.69% | -3.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.